Topics

Companies Related to "Pemf Therapy for the Management of Diabetes in Obese Patients" [Most Relevant Company Matches] RSS

12:14 EST 22nd January 2020 | BioPortfolio

Here are the most relevant search results for "Pemf Therapy for the Management of Diabetes in Obese Patients" found in our extensive corporate database of over 50,000 company records.

Showing "Pemf Therapy Management Diabetes Obese Patients" Companies 1–25 of 10,000+

Relevant

Glucox Biotech AB

The primary goal of Glucox Biotech is to develop a clinically applicable therapeutic drug for treatment of type 2 diabetes and insulin resistance. The highly favorable benefits of Glucox Biotech therapy is to decrease the critical risks and delay progression of the complications in Type 2 Diabetes patients by improving glycemic blood control. Based on its scientific excellence and with a strong mi...


Diabetes Care Partners

Diabetes Care Partners℠ (DCP) is a nationally recognized comprehensive diabetes solutions company providing all aspects of diabetes management including education, dietetic consultation, behavioral assessment and modification, and pharmacy while coordinating care across the patients’ healthcare team to engage the right patient, at the right tim...

Waratah Pharmaceuticals

Waratah is a dynamic young biopharmaceutical company founded in April 2000 as a spin-off of RTP Pharma Inc. to develop and commercialize products for its novel, patented therapy – Islet Neogenesis Therapy (I.N.T.™) for the treatment of insulin-dependent diabetes. Diabetes is a disease in which the body does not produce or properly use insulin because of damaged or destroyed insulin producing i...


Hygieia, Inc.

Hygieia, Inc. is an emerging diabetes health care company developing new ways to improve the effectiveness of therapy while reducing the cost of diabetes care. Hygieia’s first product is a handheld Diabetes Insulin Guidance System (DIGS™) designed to improve insulin therapy effectiveness for patients. DIGS works in a way that makes it a feasible ...

Vasomedical

Vasomedical Inc. provides superior medical products and services that address unmet clinical needs in the management of patients with heart disease. The company’s core technology, EECP® therapy, provides healthcare professionals a non-invasive therapy for patients suffering from cardiovascular diseases. EECP therapy helps patients and their families lead active and productive lives. With ov...

Roche Diabetes Care

Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 30 years, Roche has been committed to helping people with diabetes live lives that are as normal and active as possible and has been helping healthcare professionals manage their patients' condition in an optimal way. Today, the ACC...

Kestrel Health Media

Founded in 1998, Kestrel Health Media is a publisher of independently, clinically reviewed product references for medical professionals. Starting in the chronic wound care market, the company now has websites in incontinence care, ostomy care, dermatology, bariatrics and obese patient management, diabetes and infection control and prevention.

Diamyd Medical AB (publ)

The purpose of the GAD65-based diabetes therapy Diamyd(R) is to prevent, delay, or stop the autoimmune attack on beta cells in type 1 diabetes and other forms of autoimmune diabetes, thereby preserving the body's capacity to regulate blood sugar. This reduces the risk for both acute and long term diabetes complications significantly.

Harbor BioSciences, Inc.

Harbor BioSciences is a development-stage company with two product candidates in clinical trials: Apoptone (HE3235), in the cohort expansion portion of a Phase I/IIa trial of patients with late-stage prostate cancer, and Triolex®, in a Phase IIa trial in obese type 2 diabetes mellitus patients. Apoptone and Triolex represent the lead candidates from Harbor BioSciences' small molecule platform bas...

Bayer Diabetes Care

Bayer Diabetes Care is a worldwide leader in diabetes care, supporting customers in 100 countries and, for more than 40 years, has led the way in diabetes care product innovation. Today, Bayer Diabetes Care offers an unparalleled choice in diabetes management systems and comprehensive support including education, tools and resources designed to simplify life with diabetes. Bayer Diabetes Care is a...

Hollis-Eden Pharmaceuticals, Inc.

Hollis-Eden Pharmaceuticals is a development-stage company with two product candidates in clinical trials: Apoptone® (HE3235), in the dose-escalation portion of a Phase I/II trial of patients with late-stage prostate cancer, and Triolex®, in a Phase IIa trial in obese type 2 diabetes mellitus patients. Apoptone® and Triolex® represent the lead candidates from Hollis-Eden's small molecule pla...

MannKind

MannKind is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. Our lead investigational product candidate, Technosphere® Insulin System, is currently in phase 3 clinical trials in the U.S. and Europe to study its safety and efficacy in the treatment of diabetes. This therapy consists of a propri...

Zucara Therapeutics

Zucara Therapeutics, a spin-off company by The Centre for Drug Research and Development (CDRD) and MaRS Innovation (MI), is developing the first drug therapy to prevent hypoglycemia in people with diabetes. The Company’s first-in-class therapeutic is aimed at inhibiting a hormone in the pancreas called somatostatin, which does not function properly in ...

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients. Recent work in the laboratory of Professor Douglas Melton led to the discovery of a method to generate billions of functional, insulin-producing beta cells in the laboratory. This breakthrough technology has been exclusively licensed to Semma Therapeutics for t...

MicroIslet

MicroIslet Inc. is a biotechnology company engaged in the research, development and commercialization of patented technologies in the field of transplantation therapy for patients with diabetes. MicroIslet has licensed several technologies from Duke University Medical Center that were developed over the last decade for the isolation, culture, storage and encapsulation of insulin-producing porcine ...

Physical Therapy Pal

Physical Therapy Pal (PT PAL) is the first clinical HIPAA-compliant mobile application used between physical therapists and patients. PT PAL helps improve outcomes by engaging patients in their therapy. PT PAL gives visibility into patient regimen adherence and the ability to monitor and modify therapy prescriptions remotely. PT PAL is an aid ...

Medtronic Diabetes

At Medtronic Diabetes, our 20 plus year history vividly reflects our dedication and ongoing vision to develop an "artificial pancreas". In 1983, we pioneered the idea of continuous insulin delivery, introducing our first insulin pump in an effort to find a "better way" to deliver insulin for people with diabetes. Since that time, Medtronic Diabetes has remained the market leader, earning a reputat...

Bayer HealthCare, Diabetes Care

Bayer Diabetes Care, a worldwide leader in diabetes, supports customers in 100 countries. Since 1941, Bayer has led the way in diabetes care product innovation with: reagent tablets, the first portable blood glucose meter and test strips, the measurement of A1C (glycated hemoglobin) with the A1CNow+ monitor, and the first suite of blood glucose monitors with No Coding(TM) technology (CONTOUR and ...

Novo Nordisk

Novo Nordisk is a healthcare company and a world leader in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufac...

POPS! Diabetes Care, Inc.

POPS! is more than just a glucose monitoring system. We liberate and empower those with diabetes and their families. We transform healthcare for those with diabetes by offering a comprehensive digital health platform designed to encourage testing frequency, thereby lowering A1C count. From the simple ‘POP’ you feel when you get a blood sample to ...

Diabetes Hands Foundation

TuDiabetes.org was co-founded in 2007 by Manny Hernandez, a diabetes advocate and social media expert diagnosed with type 1 diabetes in 2002. The community is run by the Diabetes Hands Foundation, a 501c3 nonprofit that connects people touched by diabetes and raises diabetes awareness.

Emmerex

Emmerex is an early stage bio-pharmaceutical company. It aims to bring to market an anti-cancer therapy. The Emmerex therapy arose as a result of several years' biological research. It has already been proven to be safe in patients. The Emmerex therapy utilises the patients' own innate ability to fight cancer. It cuts off nutrient source of the cancer and attacks the tumours directly. The Emmerex ...

Methodist Rehabilitation Hospital

The 40-bed facility offers specialized care to patients recovering from strokes; brain and spinal cord injuries; multi-trauma, neurological disorders; cardiopulmonary procedures; and complex orthopedic surgeries such as amputations, hip fractures, and joint replacements. Amenities at the 48,000-square-foot facility include a therapeutic pool; therapy gym with the latest in rehabilitative equipment...

Inspired by Diabetes

Inspired by Diabetes is a global campaign asking people moved by the triumphs and challenges of those with diabetes and those who care for them to express their inspiration and share it with others around the world. The program is a collaboration between global champions Eli Lilly and Company, the International Diabetes Federation's (IDF) Unite for Diabetes initiative and the International Society...

Metabolex Incorporated

Metabolex discovers and develops new drugs for type 2 diabetes, bringing to the market novel drugs that address the molecular mechanisms underlying the disease. Such therapeutics are needed to more effectively control patients' blood glucose levels and impede progression of diabetes and its complications.Metabolex has a team of dedicated experts and a robust technology base in diabetes biology and...


More From BioPortfolio on "Pemf Therapy for the Management of Diabetes in Obese Patients"

Quick Search

Corporate Database Quicklinks